BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//California Life Sciences - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.califesciences.org
X-WR-CALDESC:Events for California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260616T100000
DTEND;TZID=America/Los_Angeles:20260616T110000
DTSTAMP:20260613T181431
CREATED:20260526T160015Z
LAST-MODIFIED:20260526T160015Z
UID:10001092-1781604000-1781607600@www.califesciences.org
SUMMARY:Leveraging AI and Research Platforms to Accelerate Next-Generation Biological Modalities
DESCRIPTION:As biologic modalities such as in vivo CAR therapies and antibody-drug conjugates (ADCs) rapidly advance\, the need for efficient and scalable development solutions continues to grow. \nJoin our webinar to explore how AI-enabled protein engineering\, optimized reagents\, and advanced assay platforms can support translational research\, improve reproducibility\, streamline manufacturing\, and accelerate next-generation cancer therapeutics development. \nKey highlights include:\n🔹 AI-powered protein engineering and advanced assay solutions\n🔹 Tools to improve protein interaction studies\, reproducibility\, and translational research\n🔹 Strategies to accelerate next-generation cancer therapeutic development \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/leveraging-ai-and-research-platforms-to-accelerate-next-generation-biological-modalities/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/leveraging-ai-and-research-platforms-to-accelerate-next-generation-biological-modalities/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260616T113000
DTEND;TZID=America/Los_Angeles:20260617T170000
DTSTAMP:20260613T181431
CREATED:20260609T155617Z
LAST-MODIFIED:20260609T155617Z
UID:10001098-1781609400-1781715600@www.califesciences.org
SUMMARY:Accelerating Advanced Therapies
DESCRIPTION:Progress in advanced therapies isn’t achieved in isolation. It’s shaped through shared expertise\, practical experience\, and meaningful collaboration. \nJoin Cytiva specialists and industry peers on June 16 & 17th for Accelerating Advanced Therapies\, an immersive\, in-person event centered on partnership\, insight\, and hands-on innovation across genomic medicine development and manufacturing. \nThrough practical learning and real-world discussion\, this event moves beyond theory to help you drive progress in an increasingly complex genomic medicine landscape. \n\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/accelerating-advanced-therapies/
LOCATION:10300 Campus Point Dr\, 10300 Campus Point Dr\, San Diego\, CA\, 92121\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260617T090000
DTEND;TZID=America/Los_Angeles:20260617T100000
DTSTAMP:20260613T181431
CREATED:20260603T171823Z
LAST-MODIFIED:20260603T171823Z
UID:10001096-1781686800-1781690400@www.califesciences.org
SUMMARY:From Breakthrough to Bedside: Aligning Regulatory Strategy\, Clinical Evidence and Commercialization in Diagnostics
DESCRIPTION:This panel will examine how diagnostics innovators can effectively move from concept to market adoption. The discussion will cover critical intersections between regulatory strategy\, clinical validation and commercialization\, including FDA pathways\, clinical study design and how to position programs for investment and scale. \nSpeakers include:\n› Sarah Melaney\, Pillsbury Partner (Moderator)\n› Steven Green\, Pillsbury Partner (Panelist)\n› Joen Johansen\, President & CEO of MDC Associates (Panelist)\n› Michele Colucci\, Founding Managing Partner of DigitalDX (Panelist) \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/from-breakthrough-to-bedside-aligning-regulatory-strategy-clinical-evidence-and-commercialization-in-diagnostics/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/from-breakthrough-to-bedside-aligning-regulatory-strategy-clinical-evidence-and-commercialization-in-diagnostics/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260617T120000
DTEND;TZID=America/Los_Angeles:20260617T130000
DTSTAMP:20260613T181431
CREATED:20260609T175230Z
LAST-MODIFIED:20260609T175230Z
UID:10001100-1781697600-1781701200@www.califesciences.org
SUMMARY:How to Build a Working AI System in Life Sciences – Virtual
DESCRIPTION:​Everyone in life sciences has been told to use AI. Most have not been shown properly how. \n​This is a 60-minute hands-on session for life sciences professionals who want to actually understand what AI systems do and leave having built one. \n​We’ll cover the mental model that makes everything else click: how AI systems process information\, why the tools you use behave the way they do\, and how to write instructions that produce reliable outputs. Then you’ll build a working AI agent around an example provided. No coding experience required. \n​Be ready with your LLM of choice\, and one problem you’d like AI to help with. You’ll leave with something that works. \n​Who this is for: R&D professionals\, clinicians\, post-docs\, research scientists\, and anyone in life sciences who works with AI tools and wants to understand them better. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/how-to-build-a-working-ai-system-in-life-sciences-virtual/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/how-to-build-a-working-ai-system-in-life-sciences-virtual/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260618T073000
DTEND;TZID=America/Los_Angeles:20260618T090000
DTSTAMP:20260613T181431
CREATED:20260520T223208Z
LAST-MODIFIED:20260520T223248Z
UID:10001090-1781767800-1781773200@www.califesciences.org
SUMMARY:Advanced AI for Life Sciences
DESCRIPTION:On June 18th\, Hands On and the Healthcare Businesswomen’s Association are hosting a virtual\, advanced session on AI in Life Sciences. \nHBA and non-HBA members are all welcome to attend. \nAs AI is brought more widely into use\, discover how to adopt and integrate it into your work\, whether you work in R&D\, Tech Ops\, Medical Affairs\, Commercial or G&A. \nFacilitated by an AI expert in life sciences. This session will cover: \n\n\n\nLatest trends in AI\nPragmatic applications\nWhy AI projects succeed and fail\nCurrent AI issues\n\n\n\n\nThe Future of AI\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/advanced-ai-for-life-sciences/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/advanced-ai-for-life-sciences/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260622
DTEND;VALUE=DATE:20260623
DTSTAMP:20260613T181431
CREATED:20260506T201002Z
LAST-MODIFIED:20260506T201002Z
UID:10001079-1782086400-1782172799@www.califesciences.org
SUMMARY:RESI San Diego
DESCRIPTION:RESI San Diego 2026 will take place on June 22 at the JULEP Venue San Diego during the Convention Week\, followed by FOUR (4) days of virtual partnering on June 23-24\, 29-30. Virtual partnering on the June 29-30 gives you a chance to extend your Convention-week partnering! This hybrid format combines the benefits of in-person networking with the flexibility of online interactions. \n\nCLS members receive a $200 discount on tickets and IPC packages. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/resi-san-diego/
LOCATION:JULEP Venue\, 1735 Hancock St\, San Diego\, CA\, 92101\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260622
DTEND;VALUE=DATE:20260626
DTSTAMP:20260613T181431
CREATED:20251117T211711Z
LAST-MODIFIED:20260507T160427Z
UID:10000949-1782086400-1782431999@www.califesciences.org
SUMMARY:BIO International Convention 2026
DESCRIPTION:This is the force that unites us—not the pursuit of status or stability\, but the unwavering conviction to solve the impossible\, to push boundaries\, and to achieve better outcomes for patients\, public health\, and the world. \nBIO 2026 is where we return to this essential “why.” It is our opportunity to reconnect as a global community\, to recharge our commitment\, and to remember that behind every innovation is a shared mission: to improve lives. \nConnect with the global biotech community in San Diego June 22-25\, 2026. \nLEARN MORE»
URL:https://www.califesciences.org/event/bio-international-convention-2026/
LOCATION:San Diego Convention Center\, 111 W Harbor Dr\, San Diego\, CA\, 92101\, United States
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260623T120000
DTEND;TZID=America/Los_Angeles:20260623T131500
DTSTAMP:20260613T181431
CREATED:20260526T160417Z
LAST-MODIFIED:20260526T160417Z
UID:10001093-1782216000-1782220500@www.califesciences.org
SUMMARY:The AI Data Layer: Building Trust\, Accuracy\, and Scale in Life Sciences
DESCRIPTION:Join Springer Nature for a free lunch event during BIO!\n​As biotech and pharma organizations accelerate adoption of AI across discovery\, R&D\, medical affairs\, and knowledge workflows\, the foundation for success is becoming clear: specialized\, vetted\, and well-structured scientific data underpins the most reliable outcomes and insights from AI systems. \n​Join Dr. Prathik Roy\, Product Director of AIGP Solutions at Springer Nature\, for an exclusive off-site lunch event during the BIO International Convention. The session will explore: \n\n​How semantically enriched scientific content improves downstream AI performance\n​Delivery of scientific data through scalable architectures\, including APIs\, MCP\, and private cloud deployments\n​Approaches for enabling secure\, copyright-cleared enterprise AI applications\n​How trusted scientific literature serves as an integration-ready “data layer” for retrieval-augmented generation (RAG)\, model development\, and agentic AI systems\n​Practical strategies for life sciences organizations to reduce risk in AI implementation\, strengthen the quality of outputs and build trusted infrastructure\n\n​Attendees will gain a candid\, real-world perspective grounded in experience across scientific publishing\, R&D\, and AI-enabled content access. This event is free and lunch will be provided. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/the-ai-data-layer-building-trust-accuracy-and-scale-in-life-sciences/
LOCATION:Huntress\, 376 Fifth Ave\, San Diego\, CA\, 92101\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260626T084500
DTEND;TZID=America/Los_Angeles:20260626T173000
DTSTAMP:20260613T181431
CREATED:20260506T221429Z
LAST-MODIFIED:20260506T221429Z
UID:10001085-1782463500-1782495000@www.califesciences.org
SUMMARY:Advanced ADME/PK Biopharma LC-MS/MS Method Development Training
DESCRIPTION:This one-day advanced ADME/PK biopharma LC–MS/MS method development training lab course builds on prior mass spectrometry fundamentals with a focus on workflow optimization and practical application on the Sciex platform. The program begins with a recap of prior training and defined learning objectives\, followed by a strategic overview of ADME/PK method development\, including translating project goals into LC–MS/MS workflows\, balancing throughput and data quality\, and selecting between triple quadrupole and HRMS platforms. \nParticipants then rotate through hands-on stations featuring QTRAP and ZenoTOF systems\, covering method setup and submission strategies across multiple acquisition modes. The afternoon sessions focus on data interpretation\, including quantitation using SCIEX-OS\, qualitative versus quantitative workflows\, and instrument readiness. The course concludes with an overview of advanced workflows—such as metabolite identification\, high-throughput analysis\, intact and ICE-IEF approaches\, and biotherapeutics-related methods—followed by closing reflections and discussion of future curriculum topics. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/advanced-adme-pk-biopharma-lc-ms-ms-method-development-training/
LOCATION:SCIEX\, 1201 Radio Road\, Redwood City\, CA\, 94065\, United States
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260701T100000
DTEND;TZID=America/New_York:20260701T110000
DTSTAMP:20260613T181431
CREATED:20260511T174029Z
LAST-MODIFIED:20260511T174029Z
UID:10001086-1782900000-1782903600@www.califesciences.org
SUMMARY:Streamlining Nonclinical Development with FDA NAMs
DESCRIPTION:FDA’s draft guidance on the validation of New Approach Methodologies (NAMs) is reshaping how nonclinical programs are designed and justified. This webinar explores how sponsors can apply NAMs to streamline development\, improve human relevance\, and support IND decision-making within a weight-of-evidence framework. \nWe will break down FDA expectations for validation\, including context of use and fit-for-purpose application\, and show how to position NAMs effectively in regulatory interactions. \nThrough real-world case examples spanning in vitro\, in silico\, and data-driven approaches\, attendees will gain practical insight into how NAMs can address data gaps\, reduce reliance on traditional models\, and strengthen nonclinical programs. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/streamlining-nonclinical-development-with-fda-nams/
CATEGORIES:Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/streamlining-nonclinical-development-with-fda-nams/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260701T120000
DTEND;TZID=America/Los_Angeles:20260701T130000
DTSTAMP:20260613T181431
CREATED:20260609T175454Z
LAST-MODIFIED:20260609T175454Z
UID:10001101-1782907200-1782910800@www.califesciences.org
SUMMARY:Reading the Literature in the Age of AI
DESCRIPTION:​AI literature tools are already inside your research workflow. The question is whether you know what they’re not showing you. \n​This is 60-minute virtual session for life sciences researchers who use AI tools to find\, synthesize\, or evaluate scientific literature — and want to engage with those tools more critically. \n​We open with a real published case: a Nature Communications paper that passed peer review\, generated 22\,000 views\, and contained hundreds of errors. The correction received almost none of the attention. We’ll use it to build four specific failure mechanisms that apply to every AI literature tool you use — and a set of habits that let you catch them before they propagate into your work. \n​The session ends with a live workshop: run a real research question through two different AI tools\, compare what surfaces and what doesn’t\, and identify the failure mechanisms in action. \n​No technical background needed. Just bring a research question you’d actually use. \n​Who this is for: Post-docs\, research scientists\, PIs\, and anyone in life sciences who uses AI tools for literature search\, synthesis\, or research evaluation. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/reading-the-literature-in-the-age-of-ai/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/reading-the-literature-in-the-age-of-ai/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260722T090000
DTEND;TZID=America/Los_Angeles:20260722T100000
DTSTAMP:20260613T181431
CREATED:20260611T234114Z
LAST-MODIFIED:20260611T234114Z
UID:10001103-1784710800-1784714400@www.califesciences.org
SUMMARY:A Hybrid Fragmentation Strategy for Modified Oligos
DESCRIPTION:About this webinar\nMass-spectrometric sequencing of therapeutic oligonucleotides is constrained by the choice of fragmentation method. Electron-transfer dissociation (ETD) struggles to fully fragment modified backbones — particularly locked nucleic acids (LNA) — and higher-energy collisional dissociation (HCD) produces dense spectra that are slow to interpret and prone to coverage gaps. For antisense oligos that combine LNA modifications with phosphorothioate (PS) backbones\, neither approach on its own delivers reliable end-to-end coverage. \nThis webinar presents a hybrid fragmentation approach that combines ETD and HCD in a single Orbitrap scan (EThcD)\, applied across a panel of 16-mer modified oligonucleotides — LNA-containing antisense oligos\, full PS and PO backbones\, and PS/PO mixtures. The method gives full sequence coverage from w-ions alone\, with cleaner spectra than HCD and a controlled\, a/w- and d/z-dominant fragment pattern suitable for automated assignment in Byos. Kevin will also walk through the Byos processing recipe used to interpret the data and the optimal EThcD energy identified for the 16-mer panel. \nKey Takeaways\n\nA single Orbitrap scan that covers modified oligos end-to-end. EThcD on highly-charged anionic precursors yields full w-ion coverage on LNA-containing antisense oligonucleotides and PS-backbone samples where ETD and HCD alone leave gaps.\nA counter-intuitive PS-versus-PO finding. Phosphorothioate backbones fragment more efficiently under EThcD than phosphodiester backbones — with direct implications for impurity screening in PS therapeutics.\nA practical EThcD processing recipe in Byos. Recommended energy settings\, fragment-type configuration\, and a strict-then-lenient pass strategy for confident sequence coverage and impurity detection.\n\nSpeaker\nKevin Hes — PhD candidate\, Division of BioAnalytical Chemistry & MS-LaserLab\, Vrije Universiteit Amsterdam. PhD jointly sponsored by AstraZeneca\, GSK\, and Novartis\, with funding from the Dutch Research Council (NWO); co-supervised by Anouk Rijs and Govert Somsen. Part of the InnovATOR consortium InnovATOR consortium. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/oligo-hybrid-fragmentation/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/oligo-hybrid-fragmentation/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260722T140000
DTEND;TZID=America/Los_Angeles:20260722T150000
DTSTAMP:20260613T181431
CREATED:20260610T174519Z
LAST-MODIFIED:20260610T174519Z
UID:10001102-1784728800-1784732400@www.califesciences.org
SUMMARY:From Clinical to Commercial: Talent Strategies for Biopharma Growth
DESCRIPTION:Early indications in 2026 are pointing towards a slight recovery in the biopharma job market. Join industry hiring experts for a data-informed discussion on where the life sciences job market stands today\, what trends we are witnessing in hiring and how hiring managers and HR and talent acquisition professionals can navigate shifts towards commercial readiness and/or building out commercial teams. \nThis webinar will provide a clear-eyed assessment of current hiring conditions across biopharma\, exploring how the economic climate is impacting workforce development and how hiring practices are evolving as organizations prepare to take products to market. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/from-clinical-to-commercial-talent-strategies-for-biopharma-growth/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/from-clinical-to-commercial-talent-strategies-for-biopharma-growth/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260729T090000
DTEND;TZID=America/Los_Angeles:20260729T100000
DTSTAMP:20260613T181431
CREATED:20260611T234345Z
LAST-MODIFIED:20260611T234345Z
UID:10001104-1785315600-1785319200@www.califesciences.org
SUMMARY:Footprints Without Footwork: Automated Benchtop HRPF for Binding Partners and Interfaces
DESCRIPTION:About this Webinar\nEvery protein leaves a footprint — the surface-exposed side chains that are accessible when it folds\, when it binds\, when it changes shape. Hydroxyl radical protein footprinting (HRPF) reads those footprints by oxidising the exposed residues and leaving the buried ones alone — a structural mass spectrometry technique that runs on standard laboratory equipment plus a benchtop Fenton reaction. Done by hand it is labor-intensive: multiple radical concentrations\, replicate reactions\, and dose-response curves that are sensitive to pipetting variability. Manual HRPF also limits the technique in scope — applying it across the dozens of pulldowns needed to characterise a complex becomes impractical. \nIn this webinar we show how moving the workflow onto the Opentrons Flex liquid handler tightens reproducibility and lifts throughput\, and how applying that automated workflow to affinity-purified protein complexes lets you identify binding partners and map their interaction interfaces in the same experiment. \nWhat you’ll learn in this webinar:\n\nHRPF can be performed using standard laboratory equipment to probe surface-accessible amino acids on proteins and protein complexes\nAutomating HRPF reactions on the Opentrons Flex reduces variability and increases throughput\nPerforming HRPF reactions on affinity-purified protein complexes can provide insights into binding partners and interfaces simultaneously\n\nOur Speaker:\nTyler Cropley is a Research Scientist in the Proteomics Laboratory at NYU Langone Health under the supervision of Dr. Beatrix Ueberheide. His work focuses on using mass spectrometry-based methods to study higher-order protein structure. He earned his PhD from Florida State University under the supervision of Dr. Christian Bleiholder. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/nyu-footprint-2026/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
LOCATION:https://www.califesciences.org/event/nyu-footprint-2026/
END:VEVENT
END:VCALENDAR